Chemoembolization of Hepatocellular Carcinoma with Portal Vein Thrombosis
Liu Qi; Jia Yuchen; He Jia; et al.(Changhai Hospital,Second Military Medicdl University,Shanghai 200433)
One hundred twenty-eight patients of hepatocellular carcinoma with portal vein thrombosis underwent more than 2 times interventional treatnient.The patients were divided into 3 groups according to the method of therapy, group A, hepatic transarterial chemotherapy alone;group B,chemotherapy and lipiodol embolization ,group C,chemotherapy,lipiodol and gelfoam em-bolization,The one year survival rates of the three groups were 25.00%, 28.52% and 41.76%,re-spectively. The median durations of survival were 184.108.40.206 and 10.3 months respectively. The cura-tive effect of group C was the best and included one long-term:urvivor(7years); The results showed that portal vein thrombosis should not be considered as contraindication to hepatic chemoem-bolization which could be used if hepatic cirrhosis is not severe and liver functions are not severelv im-paired.
【CateGory Index】： R735.705